Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Coupier

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Neuro-Oncology|August 2, 2024
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumorsGrégory Thomson, Mathilde Filser, Léa Guerrini-Rousseau, et al.
Breast Cancer Research : BCR|July 6, 2012
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2011
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumorFranck Bourdeaut, Delphine Lequin, Laurence Brugières, et al.
European Journal of Human Genetics : EJHG|January 21, 2016
Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS studyAmandine I Garcia, Monique Buisson, Francesca Damiola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2015
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 CarriersJulie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2020
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni SyndromeLaura Mezquita, Maria Jové, Ernest Nadal, et al.
Human Mutation|June 17, 2015
Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith-Wiedemann Syndrome: Clinical Spectrum and Functional CharacterizationFrederic Brioude, Irène Netchine, Francoise Praz, et al.
Carcinogenesis|October 6, 2017
Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia familiesAnne-Laure Renault, Noura Mebirouk, Eve Cavaciuti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 29, 2026
Cancer risks for ATM variant heterozygotesYue Jiao, David E Goldgar, Dorothée Le Gal, et al.
International Journal of Cancer|May 19, 2005
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 geneDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Neuro-Oncology|August 2, 2024
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumorsGrégory Thomson, Mathilde Filser, Léa Guerrini-Rousseau, et al.
Breast Cancer Research : BCR|July 6, 2012
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2011
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumorFranck Bourdeaut, Delphine Lequin, Laurence Brugières, et al.
European Journal of Human Genetics : EJHG|January 21, 2016
Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS studyAmandine I Garcia, Monique Buisson, Francesca Damiola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2015
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 CarriersJulie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2020
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni SyndromeLaura Mezquita, Maria Jové, Ernest Nadal, et al.
Human Mutation|June 17, 2015
Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith-Wiedemann Syndrome: Clinical Spectrum and Functional CharacterizationFrederic Brioude, Irène Netchine, Francoise Praz, et al.
Carcinogenesis|October 6, 2017
Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia familiesAnne-Laure Renault, Noura Mebirouk, Eve Cavaciuti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 29, 2026
Cancer risks for ATM variant heterozygotesYue Jiao, David E Goldgar, Dorothée Le Gal, et al.
International Journal of Cancer|May 19, 2005
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 geneDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
Pageof 7